Development of a somatic variant registry in a National Cancer Center: towards Molecular Real World Data preparedness.

Cancer Genomics Clinical Bioinformatics Data Engineering FAIR Molecular Tumor Registries Somatic Variant Databases

Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
06 2023
Historique:
received: 12 11 2022
revised: 21 03 2023
accepted: 14 05 2023
medline: 5 6 2023
pubmed: 21 5 2023
entrez: 20 5 2023
Statut: ppublish

Résumé

The Biomedical Research field is currently advancing to develop Clinical Trials and translational projects based on Real World Evidence. To make this transition feasible, clinical centers need to work toward Data Accessibility and Interoperability. This task is particularly challenging when applied to Genomics, that entered in routinary screening in the last years via mostly amplicon-based Next-Generation Sequencing panels. Said experiments produce up to hundreds of features per patient, and their summarized results are often stored in static clinical reports, making critical information inaccessible to automated access and Federated Search consortia. In this study, we present a reanalysis of 4620 solid tumor sequencing samples in five different histology settings. Furthermore, we describe all the Bioinformatics and Data Engineering processes that were put in place in order to create a Somatic Variant Registry able to deal with the large biotechnological variability of routinary Genomics Profiling.

Identifiants

pubmed: 37209976
pii: S1532-0464(23)00115-6
doi: 10.1016/j.jbi.2023.104394
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104394

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Martina Betti (M)

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Chiara Maria Salzano (C)

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Alice Massacci (A)

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Mattia D'Antonio (M)

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Isabella Grassucci (I)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Benedetta Marcozzi (B)

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Marco Canfora (M)

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Elisa Melucci (E)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Simonetta Buglioni (S)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Beatrice Casini (B)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Enzo Gallo (E)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Edoardo Pescarmona (E)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Gennaro Ciliberto (G)

Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Matteo Pallocca (M)

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: matteo.pallocca@ifo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH